Claret Asset Management Corp Pro Mis Neurosciences Inc. Transaction History
Claret Asset Management Corp
- $772 Million
- Q2 2025
A detailed history of Claret Asset Management Corp transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Claret Asset Management Corp holds 11,330 shares of PMN stock, worth $4,985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,330
Previous 11,330
-0.0%
Holding current value
$4,985
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PMN
# of Institutions
20Shares Held
8.47MCall Options Held
0Put Options Held
0-
Great Point Partners LLC Greenwich, CT2.65MShares$1.16 Million1.05% of portfolio
-
Armistice Capital, LLC New York, NY2.14MShares$940,6740.02% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.9MShares$835,6900.25% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY1.33MShares$587,1480.92% of portfolio
-
Allostery Investments LP Stamford, CT156KShares$68,5160.97% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...